The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...

Oxford Nanopore Technologies, which develops and sells nanopore sequencing products, has announced the expansion of its Compatible Products Programme. These products are used for DNA or RNA sequencing ...

In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) just unveiled an update. Oxford Nanopore Technologies PLC announced a transaction involving its ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced the publication of a comprehensive review in JAMA Oncology that strengthens the evidence supporting ...

Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now integrate seamlessly with Oxford ...

The FTSE 250 can be overlooked by investors, but analysts believe this stock in particular could be undervalued by as much as ...

A biomolecular engineering course has recently been redesigned to give students experience with the entire process of DNA ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent ...

However, the existing sequencing technologies are expensive and require time-consuming sample preparation and sequencing runs, which constrain their global use. Oxford Nanopore sequencing overcomes ...